speb/financial-data huggingface dataset:
HGEA.DE balance_sheet (quarterly, 2025-12-31) — Other Receivables: 781000.00
HGEA.DE income_statement (annual, 2025-12-31) — Other Special Charges: -81000.00
HGEA.DE income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
HGEA.DE balance_sheet (annual, 2025-12-31) — Payables: 14249000.00
HGEA.DE balance_sheet (quarterly, 2025-12-31) — Payables: 14249000.00
HGEA.DE balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4084000.00
HGEA.DE balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4084000.00
HGEA.DE balance_sheet (annual, 2025-12-31) — Prepaid Assets: 508000.00
HGEA.DE balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 508000.00
HGEA.DE income_statement (annual, 2025-12-31) — Pretax Income: -28148000.00
HGEA.DE balance_sheet (annual, 2025-12-31) — Properties: 18932000.00
HGEA.DE balance_sheet (quarterly, 2025-12-31) — Properties: 18932000.00
HGEA.DE cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: -195000.00
HGEA.DE cash_flow (annual, 2025-12-31) — Purchase Of Investment: -5495000.00
HGEA.DE balance_sheet (annual, 2025-12-31) — Raw Materials: 10895000.00
HGEA.DE balance_sheet (quarterly, 2025-12-31) — Raw Materials: 10895000.00
HGEA.DE income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 49666000.00
HGEA.DE income_statement (annual, 2025-12-31) — Reconciled Depreciation: 10925000.00
HGEA.DE income_statement (annual, 2025-12-31) — Rent And Landing Fees: 513000.00
HGEA.DE income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 513000.00
HGEA.DE cash_flow (annual, 2025-12-31) — Repayment Of Debt: -22863000.00
HGEA.DE balance_sheet (annual, 2025-12-31) — Retained Earnings: -57371000.00
HGEA.DE balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -57371000.00
HGEA.DE cash_flow (annual, 2025-12-31) — Sale Of PPE: 2524000.00
HGEA.DE income_statement (annual, 2025-12-31) — Selling General And Administration: 4707000.00
HGEA.DE balance_sheet (annual, 2025-12-31) — Share Issued: 10400000.00
HGEA.DE balance_sheet (quarterly, 2025-12-31) — Share Issued: 10400000.00
HGEA.DE income_statement (annual, 2025-12-31) — Special Income Charges: 64000.00
HGEA.DE balance_sheet (annual, 2025-12-31) — Stockholders Equity: 24359000.00
HGEA.DE balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 24359000.00
HGEA.DE balance_sheet (annual, 2025-12-31) — Tangible Book Value: 23932000.00
HGEA.DE balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 23932000.00
HGEA.DE income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 704.00
HGEA.DE income_statement (annual, 2025-12-31) — Tax Provision: -304000.00
HGEA.DE income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.01
HGEA.DE balance_sheet (annual, 2025-12-31) — Taxes Receivable: 1610000.00
HGEA.DE balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 1610000.00
HGEA.DE cash_flow (annual, 2025-12-31) — Taxes Refund Paid: 233000.00
HGEA.DE balance_sheet (annual, 2025-12-31) — Total Assets: 76271000.00
HGEA.DE balance_sheet (quarterly, 2025-12-31) — Total Assets: 76271000.00
HGEA.DE balance_sheet (annual, 2025-12-31) — Total Capitalization: 34238000.00
HGEA.DE balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 34238000.00
HGEA.DE balance_sheet (annual, 2025-12-31) — Total Debt: 27174000.00
HGEA.DE balance_sheet (quarterly, 2025-12-31) — Total Debt: 27174000.00
HGEA.DE balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 24359000.00
HGEA.DE balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 24359000.00
HGEA.DE income_statement (annual, 2025-12-31) — Total Expenses: 117581000.00
HGEA.DE balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 51912000.00
HGEA.DE balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 51912000.00
HGEA.DE balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 42693000.00
HGEA.DE balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 42693000.00
HGEA.DE balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 17397000.00
HGEA.DE balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 17397000.00
HGEA.DE income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -25673000.00
HGEA.DE balance_sheet (annual, 2025-12-31) — Total Tax Payable: 12000.00
HGEA.DE balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 12000.00
HGEA.DE income_statement (annual, 2025-12-31) — Total Unusual Items: 64000.00
HGEA.DE income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 64000.00
HGEA.DE balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 161000.00
HGEA.DE balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 161000.00
HGEA.DE balance_sheet (annual, 2025-12-31) — Working Capital: -937000.00
HGEA.DE balance_sheet (quarterly, 2025-12-31) — Working Capital: -937000.00
HGEA.DE income_statement (annual, 2025-12-31) — Write Off: 17000.00
HGH.AX balance_sheet (annual, 2021-06-30) — Current Deferred Liabilities: 7440000.00
HGH.AX balance_sheet (annual, 2021-06-30) — Current Deferred Taxes Liabilities: 7440000.00
HGH.AX cash_flow (annual, 2021-06-30) — Issuance Of Debt: 81801000.00
HGH.AX cash_flow (annual, 2021-06-30) — Long Term Debt Issuance: 81801000.00
HGH.AX income_statement (annual, 2022-06-30) — +Total Revenue: 264349000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Accounts Payable: 21358000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Accounts Receivable: 6143675000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: -5289000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Allowance For Doubtful Accounts Receivable: -52005000.00
HGH.AX income_statement (annual, 2022-06-30) — Amortization: 5922000.00
HGH.AX income_statement (annual, 2022-06-30) — Amortization Of Intangibles Income Statement: 5922000.00
HGH.AX income_statement (annual, 2022-06-30) — Basic Average Shares: 603637583.00
HGH.AX income_statement (annual, 2022-06-30) — Basic EPS: 0.16
HGH.AX cash_flow (annual, 2022-06-30) — Beginning Cash Position: 182333000.00
HGH.AX cash_flow (annual, 2022-06-30) — Capital Expenditure: -9809000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Capital Stock: 599185000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 572017000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Federal Funds Sold: 572017000.00
HGH.AX cash_flow (annual, 2022-06-30) — Cash Dividends Paid: -58050000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Cash Financial: 310758000.00
HGH.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: 484936000.00
HGH.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -94197000.00
HGH.AX cash_flow (annual, 2022-06-30) — Cash Flowsfromusedin Operating Activities Direct: -262314000.00
HGH.AX cash_flow (annual, 2022-06-30) — Changes In Cash: 128425000.00
HGH.AX cash_flow (annual, 2022-06-30) — Classesof Cash Payments: -202917000.00
HGH.AX cash_flow (annual, 2022-06-30) — Classesof Cash Receiptsfrom Operating Activities: -59397000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Common Stock: 599185000.00
HGH.AX cash_flow (annual, 2022-06-30) — Common Stock Dividend Paid: -58050000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Common Stock Equity: 808707000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Current Debt: 1958046000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Current Debt And Capital Lease Obligation: 1958046000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Current Deferred Liabilities: 22044000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Current Deferred Taxes Liabilities: 22044000.00
HGH.AX income_statement (annual, 2022-06-30) — Depreciation Amortization Depletion Income Statement: 13794000.00
HGH.AX income_statement (annual, 2022-06-30) — Depreciation And Amortization In Income Statement: 13794000.00
HGH.AX income_statement (annual, 2022-06-30) — Depreciation Income Statement: 7872000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Derivative Product Liabilities: 6341000.00
HGH.AX income_statement (annual, 2022-06-30) — Diluted Average Shares: 603637583.00
HGH.AX income_statement (annual, 2022-06-30) — Diluted EPS: 0.16
HGH.AX cash_flow (annual, 2022-06-30) — End Cash Position: 310758000.00
HGH.AX cash_flow (annual, 2022-06-30) — Financing Cash Flow: 484936000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Foreign Currency Translation Adjustments: -1635000.00
HGH.AX cash_flow (annual, 2022-06-30) — Free Cash Flow: -272123000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: 9936000.00
HGH.AX income_statement (annual, 2022-06-30) — General And Administrative Expense: 2679000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Goodwill: 183235000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Goodwill And Other Intangible Assets: 218874000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Gross Accounts Receivable: 6195680000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Gross PPE: 34595000.00
HGH.AX cash_flow (annual, 2022-06-30) — Income Tax Paid Supplemental Data: 32987000.00
HGH.AX income_statement (annual, 2022-06-30) — Interest Expense: 91959000.00
HGH.AX income_statement (annual, 2022-06-30) — Interest Income: 342101000.00
HGH.AX cash_flow (annual, 2022-06-30) — Interest Paid Supplemental Data: 100467000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Invested Capital: 3403160000.00
HGH.AX cash_flow (annual, 2022-06-30) — Investing Cash Flow: -94197000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Investments And Advances: 39867000.00
HGH.AX cash_flow (annual, 2022-06-30) — Issuance Of Debt: 77243000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Long Term Debt: 636407000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Long Term Debt And Capital Lease Obligation: 636407000.00
HGH.AX cash_flow (annual, 2022-06-30) — Long Term Debt Issuance: 77243000.00
HGH.AX cash_flow (annual, 2022-06-30) — Long Term Debt Payments: -2396000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Long Term Equity Investment: 15082000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Machinery Furniture Equipment: 34595000.00
HGH.AX cash_flow (annual, 2022-06-30) — Net Business Purchase And Sale: -159919000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Net Debt: 2022436000.00
HGH.AX income_statement (annual, 2022-06-30) — Net Income: 95125000.00
HGH.AX income_statement (annual, 2022-06-30) — Net Income Common Stockholders: 95125000.00
HGH.AX income_statement (annual, 2022-06-30) — Net Income Continuous Operations: 95125000.00
HGH.AX income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: 95125000.00
HGH.AX income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: 95125000.00
HGH.AX income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: 95125000.00
HGH.AX income_statement (annual, 2022-06-30) — Net Interest Income: 250142000.00
HGH.AX cash_flow (annual, 2022-06-30) — Net Investment Purchase And Sale: 75531000.00
HGH.AX cash_flow (annual, 2022-06-30) — Net Issuance Payments Of Debt: 74847000.00
HGH.AX cash_flow (annual, 2022-06-30) — Net Long Term Debt Issuance: 74847000.00
HGH.AX cash_flow (annual, 2022-06-30) — Net Other Financing Charges: 468139000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Net PPE: 29306000.00
HGH.AX cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -9809000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 589833000.00
HGH.AX income_statement (annual, 2022-06-30) — Normalized Income: 95125000.00
HGH.AX income_statement (annual, 2022-06-30) — Occupancy And Equipment: 280000.00
HGH.AX income_statement (annual, 2022-06-30) — Operating Revenue: 264349000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 607148369.00
HGH.AX cash_flow (annual, 2022-06-30) — Other Cash Receiptsfrom Operating Activities: -296786000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Other Current Borrowings: 1958046000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Other Equity Adjustments: 11571000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Other Intangible Assets: 35639000.00
HGH.AX income_statement (annual, 2022-06-30) — Other Non Interest Expense: 100271000.00
HGH.AX income_statement (annual, 2022-06-30) — Other Non Operating Income Expenses: 6651000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Other Payable: 44852000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Other Receivables: 3219000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Other Short Term Investments: 24785000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Payables: 66210000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 66210000.00
HGH.AX income_statement (annual, 2022-06-30) — Pretax Income: 137041000.00
HGH.AX income_statement (annual, 2022-06-30) — Professional Expense And Contract Services Expense: 3112000.00
HGH.AX cash_flow (annual, 2022-06-30) — Purchase Of Business: -159919000.00
HGH.AX cash_flow (annual, 2022-06-30) — Purchase Of PPE: -9809000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Receivables: 6146894000.00
HGH.AX income_statement (annual, 2022-06-30) — Reconciled Depreciation: 13794000.00
HGH.AX cash_flow (annual, 2022-06-30) — Repayment Of Debt: -2396000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Retained Earnings: 199586000.00
HGH.AX income_statement (annual, 2022-06-30) — Salaries And Wages: 2679000.00
HGH.AX cash_flow (annual, 2022-06-30) — Sale Of Investment: 75531000.00
HGH.AX income_statement (annual, 2022-06-30) — Selling General And Administration: 2679000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Share Issued: 607148369.00
HGH.AX balance_sheet (annual, 2022-06-30) — Stockholders Equity: 808707000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Tangible Book Value: 589833000.00
HGH.AX income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 0.00
HGH.AX income_statement (annual, 2022-06-30) — Tax Provision: 41916000.00
HGH.AX income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.31
HGH.AX balance_sheet (annual, 2022-06-30) — Total Assets: 7090263000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Total Capitalization: 1445114000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Total Debt: 2594453000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 808707000.00
HGH.AX balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 6281556000.00
HGH.AX income_statement (annual, 2023-06-30) — +Total Revenue: 282132000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Accounts Payable: 14731000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Accounts Receivable: 6738024000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Accumulated Depreciation: -8486000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Allowance For Doubtful Accounts Receivable: -53266000.00
HGH.AX income_statement (annual, 2023-06-30) — Amortization: 5681000.00
HGH.AX income_statement (annual, 2023-06-30) — Amortization Of Intangibles Income Statement: 5681000.00
HGH.AX income_statement (annual, 2023-06-30) — Basic Average Shares: 702928463.00
HGH.AX income_statement (annual, 2023-06-30) — Basic EPS: 0.14
HGH.AX cash_flow (annual, 2023-06-30) — Beginning Cash Position: 310758000.00
HGH.AX cash_flow (annual, 2023-06-30) — Capital Expenditure: -24669000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Capital Stock: 800712000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 616813000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Federal Funds Sold: 616813000.00
HGH.AX cash_flow (annual, 2023-06-30) — Cash Dividends Paid: -64303000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Cash Financial: 311503000.00
HGH.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: 37695000.00
HGH.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: -78232000.00
HGH.AX cash_flow (annual, 2023-06-30) — Cash Flowsfromusedin Operating Activities Direct: 42689000.00
HGH.AX cash_flow (annual, 2023-06-30) — Changes In Cash: 2152000.00
HGH.AX cash_flow (annual, 2023-06-30) — Classesof Cash Payments: -376503000.00
HGH.AX cash_flow (annual, 2023-06-30) — Classesof Cash Receiptsfrom Operating Activities: 419192000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Common Stock: 800712000.00
HGH.AX cash_flow (annual, 2023-06-30) — Common Stock Dividend Paid: -64303000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Common Stock Equity: 1031004000.00
HGH.AX cash_flow (annual, 2023-06-30) — Common Stock Issuance: 193364000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Current Debt: 2027386000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Current Debt And Capital Lease Obligation: 2027386000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Current Deferred Liabilities: 6112000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Current Deferred Taxes Liabilities: 6112000.00
HGH.AX income_statement (annual, 2023-06-30) — Depreciation Amortization Depletion Income Statement: 13585000.00
HGH.AX income_statement (annual, 2023-06-30) — Depreciation And Amortization In Income Statement: 13585000.00
HGH.AX income_statement (annual, 2023-06-30) — Depreciation Income Statement: 7904000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Derivative Product Liabilities: 7624000.00
HGH.AX income_statement (annual, 2023-06-30) — Diluted Average Shares: 702928463.00
HGH.AX income_statement (annual, 2023-06-30) — Diluted EPS: 0.14
HGH.AX cash_flow (annual, 2023-06-30) — Effect Of Exchange Rate Changes: -1407000.00
HGH.AX cash_flow (annual, 2023-06-30) — End Cash Position: 311503000.00
HGH.AX cash_flow (annual, 2023-06-30) — Financing Cash Flow: 37695000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Foreign Currency Translation Adjustments: -8438000.00
HGH.AX cash_flow (annual, 2023-06-30) — Free Cash Flow: 18020000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: 6240000.00
HGH.AX income_statement (annual, 2023-06-30) — General And Administrative Expense: 3223000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Goodwill: 184422000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Goodwill And Other Intangible Assets: 235733000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Gross Accounts Receivable: 6791290000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Gross PPE: 52011000.00
HGH.AX cash_flow (annual, 2023-06-30) — Income Tax Paid Supplemental Data: 54629000.00
HGH.AX income_statement (annual, 2023-06-30) — Interest Expense: 245721000.00
HGH.AX income_statement (annual, 2023-06-30) — Interest Income: 527710000.00
HGH.AX cash_flow (annual, 2023-06-30) — Interest Paid Supplemental Data: 193679000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Invested Capital: 3541666000.00
HGH.AX cash_flow (annual, 2023-06-30) — Investing Cash Flow: -78232000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Investments And Advances: 36833000.00
HGH.AX cash_flow (annual, 2023-06-30) — Issuance Of Capital Stock: 193364000.00
HGH.AX cash_flow (annual, 2023-06-30) — Issuance Of Debt: 185523000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Long Term Debt: 483276000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Long Term Debt And Capital Lease Obligation: 483276000.00
HGH.AX cash_flow (annual, 2023-06-30) — Long Term Debt Issuance: 185523000.00
HGH.AX cash_flow (annual, 2023-06-30) — Long Term Debt Payments: -332956000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Long Term Equity Investment: 15048000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Machinery Furniture Equipment: 52011000.00
HGH.AX cash_flow (annual, 2023-06-30) — Net Business Purchase And Sale: -3047000.00
HGH.AX cash_flow (annual, 2023-06-30) — Net Common Stock Issuance: 193364000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Net Debt: 1893849000.00
HGH.AX income_statement (annual, 2023-06-30) — Net Income: 95868000.00
HGH.AX income_statement (annual, 2023-06-30) — Net Income Common Stockholders: 95868000.00
HGH.AX income_statement (annual, 2023-06-30) — Net Income Continuous Operations: 95868000.00
HGH.AX income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: 95868000.00
HGH.AX income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: 95868000.00
HGH.AX income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: 95868000.00
HGH.AX income_statement (annual, 2023-06-30) — Net Interest Income: 281989000.00
HGH.AX cash_flow (annual, 2023-06-30) — Net Investment Purchase And Sale: -46580000.00
HGH.AX cash_flow (annual, 2023-06-30) — Net Issuance Payments Of Debt: -147433000.00
HGH.AX cash_flow (annual, 2023-06-30) — Net Long Term Debt Issuance: -147433000.00
HGH.AX cash_flow (annual, 2023-06-30) — Net Other Financing Charges: 56067000.00
HGH.AX cash_flow (annual, 2023-06-30) — Net Other Investing Changes: -3936000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Net PPE: 43525000.00
HGH.AX cash_flow (annual, 2023-06-30) — Net PPE Purchase And Sale: -24669000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Net Tangible Assets: 795271000.00
HGH.AX income_statement (annual, 2023-06-30) — Normalized Income: 95868000.00
HGH.AX income_statement (annual, 2023-06-30) — Occupancy And Equipment: 2107000.00
HGH.AX income_statement (annual, 2023-06-30) — Operating Revenue: 282132000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 726707354.00
HGH.AX cash_flow (annual, 2023-06-30) — Other Cash Receiptsfrom Operating Activities: 69963000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Other Current Borrowings: 2027386000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Other Equity Adjustments: 14678000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Other Intangible Assets: 51311000.00
HGH.AX income_statement (annual, 2023-06-30) — Other Non Interest Expense: 108349000.00
HGH.AX income_statement (annual, 2023-06-30) — Other Non Operating Income Expenses: 7011000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Other Payable: 43567000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Other Receivables: 1818000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Other Short Term Investments: 21785000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Payables: 58298000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 58298000.00
HGH.AX income_statement (annual, 2023-06-30) — Pretax Income: 133993000.00
HGH.AX income_statement (annual, 2023-06-30) — Professional Expense And Contract Services Expense: 4642000.00
HGH.AX cash_flow (annual, 2023-06-30) — Purchase Of Business: -3047000.00
HGH.AX cash_flow (annual, 2023-06-30) — Purchase Of Investment: -102023000.00
HGH.AX cash_flow (annual, 2023-06-30) — Purchase Of PPE: -24669000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Receivables: 6739842000.00
HGH.AX income_statement (annual, 2023-06-30) — Reconciled Depreciation: 13585000.00
HGH.AX cash_flow (annual, 2023-06-30) — Repayment Of Debt: -332956000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Retained Earnings: 224052000.00
HGH.AX income_statement (annual, 2023-06-30) — Salaries And Wages: 3223000.00
HGH.AX cash_flow (annual, 2023-06-30) — Sale Of Investment: 55443000.00
HGH.AX income_statement (annual, 2023-06-30) — Selling General And Administration: 3223000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Share Issued: 726707354.00
HGH.AX balance_sheet (annual, 2023-06-30) — Stockholders Equity: 1031004000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Tangible Book Value: 795271000.00
HGH.AX income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: 0.00
HGH.AX income_statement (annual, 2023-06-30) — Tax Provision: 38125000.00
HGH.AX income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.28
HGH.AX balance_sheet (annual, 2023-06-30) — Total Assets: 7744725000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Total Capitalization: 1514280000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Total Debt: 2510662000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 1031004000.00
HGH.AX balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 6713721000.00
HGH.AX income_statement (annual, 2024-06-30) — +Total Revenue: 288456000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Accounts Payable: 17158000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Accounts Receivable: 7164764000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Accumulated Depreciation: -11182000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Allowance For Doubtful Accounts Receivable: -76321000.00
HGH.AX income_statement (annual, 2024-06-30) — Amortization: 5516000.00
HGH.AX income_statement (annual, 2024-06-30) — Amortization Of Intangibles Income Statement: 5516000.00
HGH.AX income_statement (annual, 2024-06-30) — Basic Average Shares: 757046000.00
HGH.AX income_statement (annual, 2024-06-30) — Basic EPS: 0.10
HGH.AX cash_flow (annual, 2024-06-30) — Beginning Cash Position: 311503000.00
HGH.AX cash_flow (annual, 2024-06-30) — Capital Expenditure: -28091000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Capital Stock: 1018954000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 900200000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Federal Funds Sold: 900200000.00
HGH.AX cash_flow (annual, 2024-06-30) — Cash Dividends Paid: -57714000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Cash Financial: 629619000.00
HGH.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Financing Activities: -358637000.00
HGH.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: -253380000.00
HGH.AX cash_flow (annual, 2024-06-30) — Cash Flowsfromusedin Operating Activities Direct: 928353000.00
HGH.AX cash_flow (annual, 2024-06-30) — Changes In Cash: 316336000.00
HGH.AX cash_flow (annual, 2024-06-30) — Classesof Cash Payments: -530267000.00
HGH.AX cash_flow (annual, 2024-06-30) — Classesof Cash Receiptsfrom Operating Activities: 1458620000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Common Stock: 1018954000.00
HGH.AX cash_flow (annual, 2024-06-30) — Common Stock Dividend Paid: -57714000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Common Stock Equity: 1237869000.00
HGH.AX cash_flow (annual, 2024-06-30) — Common Stock Issuance: 204001000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Current Debt: 1446788000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Current Debt And Capital Lease Obligation: 1446788000.00
HGH.AX income_statement (annual, 2024-06-30) — Depreciation Amortization Depletion Income Statement: 14479000.00
HGH.AX income_statement (annual, 2024-06-30) — Depreciation And Amortization In Income Statement: 14479000.00
HGH.AX income_statement (annual, 2024-06-30) — Depreciation Income Statement: 8963000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Derivative Product Liabilities: 9017000.00
HGH.AX income_statement (annual, 2024-06-30) — Diluted Average Shares: 757046000.00
HGH.AX income_statement (annual, 2024-06-30) — Diluted EPS: 0.10
HGH.AX cash_flow (annual, 2024-06-30) — Effect Of Exchange Rate Changes: 1780000.00
HGH.AX cash_flow (annual, 2024-06-30) — End Cash Position: 629619000.00
HGH.AX cash_flow (annual, 2024-06-30) — Financing Cash Flow: -358637000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Foreign Currency Translation Adjustments: -6665000.00
HGH.AX cash_flow (annual, 2024-06-30) — Free Cash Flow: 900262000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Gains Losses Not Affecting Retained Earnings: -8496000.00
HGH.AX income_statement (annual, 2024-06-30) — General And Administrative Expense: 3595000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Goodwill: 208723000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Goodwill And Other Intangible Assets: 279906000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Gross Accounts Receivable: 7241085000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Gross PPE: 66993000.00
HGH.AX cash_flow (annual, 2024-06-30) — Income Tax Paid Supplemental Data: 46842000.00
HGH.AX income_statement (annual, 2024-06-30) — Interest Expense: 383387000.00
HGH.AX income_statement (annual, 2024-06-30) — Interest Income: 661032000.00
HGH.AX cash_flow (annual, 2024-06-30) — Interest Paid Supplemental Data: 327643000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Invested Capital: 3296408000.00
HGH.AX cash_flow (annual, 2024-06-30) — Investing Cash Flow: -253380000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Investments And Advances: 825210000.00
HGH.AX cash_flow (annual, 2024-06-30) — Issuance Of Capital Stock: 204001000.00
HGH.AX cash_flow (annual, 2024-06-30) — Issuance Of Debt: 241160000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Long Term Debt: 611751000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Long Term Debt And Capital Lease Obligation: 611751000.00
HGH.AX cash_flow (annual, 2024-06-30) — Long Term Debt Issuance: 241160000.00
HGH.AX cash_flow (annual, 2024-06-30) — Long Term Debt Payments: -126808000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Long Term Equity Investment: 13475000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Machinery Furniture Equipment: 66993000.00
HGH.AX cash_flow (annual, 2024-06-30) — Net Business Purchase And Sale: 165620000.00
HGH.AX cash_flow (annual, 2024-06-30) — Net Common Stock Issuance: 204001000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Net Debt: 1158339000.00
HGH.AX income_statement (annual, 2024-06-30) — Net Income: 74549000.00
HGH.AX income_statement (annual, 2024-06-30) — Net Income Common Stockholders: 74549000.00
HGH.AX income_statement (annual, 2024-06-30) — Net Income Continuous Operations: 74549000.00
HGH.AX income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: 74549000.00
HGH.AX income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: 74549000.00
HGH.AX income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: 74549000.00
HGH.AX income_statement (annual, 2024-06-30) — Net Interest Income: 277645000.00
HGH.AX cash_flow (annual, 2024-06-30) — Net Investment Purchase And Sale: -390909000.00
HGH.AX cash_flow (annual, 2024-06-30) — Net Issuance Payments Of Debt: 114352000.00
HGH.AX cash_flow (annual, 2024-06-30) — Net Long Term Debt Issuance: 114352000.00
HGH.AX cash_flow (annual, 2024-06-30) — Net Other Financing Charges: -619276000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Net PPE: 55811000.00
HGH.AX cash_flow (annual, 2024-06-30) — Net PPE Purchase And Sale: -28091000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Net Tangible Assets: 957963000.00
HGH.AX income_statement (annual, 2024-06-30) — Normalized Income: 74549000.00
HGH.AX income_statement (annual, 2024-06-30) — Occupancy And Equipment: 3059000.00
HGH.AX income_statement (annual, 2024-06-30) — Operating Revenue: 288456000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Ordinary Shares Number: 930561000.00
HGH.AX cash_flow (annual, 2024-06-30) — Other Cash Receiptsfrom Operating Activities: 1010940000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Other Current Borrowings: 1446788000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Other Equity Adjustments: -1831000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Other Intangible Assets: 71183000.00
HGH.AX income_statement (annual, 2024-06-30) — Other Non Interest Expense: 116386000.00
HGH.AX income_statement (annual, 2024-06-30) — Other Non Operating Income Expenses: 6271000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Other Payable: 20156000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Other Receivables: 6936000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Other Short Term Investments: 104895000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Payables: 37314000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Payables And Accrued Expenses: 37314000.00
HGH.AX income_statement (annual, 2024-06-30) — Pretax Income: 104545000.00
HGH.AX income_statement (annual, 2024-06-30) — Professional Expense And Contract Services Expense: 6240000.00
HGH.AX cash_flow (annual, 2024-06-30) — Purchase Of Investment: -637399000.00
HGH.AX cash_flow (annual, 2024-06-30) — Purchase Of PPE: -28091000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Receivables: 7171700000.00
HGH.AX income_statement (annual, 2024-06-30) — Reconciled Depreciation: 14479000.00
HGH.AX cash_flow (annual, 2024-06-30) — Repayment Of Debt: -126808000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Retained Earnings: 227411000.00
HGH.AX income_statement (annual, 2024-06-30) — Salaries And Wages: 3595000.00
HGH.AX cash_flow (annual, 2024-06-30) — Sale Of Business: 165620000.00
HGH.AX cash_flow (annual, 2024-06-30) — Sale Of Investment: 246490000.00
HGH.AX income_statement (annual, 2024-06-30) — Selling General And Administration: 3595000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Share Issued: 930561000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Stockholders Equity: 1237869000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Tangible Book Value: 957963000.00
HGH.AX income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: 0.00
HGH.AX income_statement (annual, 2024-06-30) — Tax Provision: 29996000.00
HGH.AX income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.29
HGH.AX balance_sheet (annual, 2024-06-30) — Total Assets: 9291855000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Total Capitalization: 1849620000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Total Debt: 2058539000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Total Equity Gross Minority Interest: 1237869000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 8053986000.00
HGH.AX balance_sheet (annual, 2024-06-30) — Trading Securities: 706840000.00
HGH.AX income_statement (annual, 2025-06-30) — +Total Revenue: 319129000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Accounts Payable: 16453000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 16453000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Accounts Receivable: 7082399000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 7082399000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Accumulated Depreciation: -13028000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -13028000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -73283000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -73283000.00
HGH.AX income_statement (annual, 2025-06-30) — Amortization: 11509000.00
HGH.AX income_statement (annual, 2025-06-30) — Amortization Of Intangibles Income Statement: 11509000.00
HGH.AX income_statement (annual, 2025-06-30) — Basic Average Shares: 936613000.00
HGH.AX income_statement (annual, 2025-06-30) — Basic EPS: 0.04
HGH.AX cash_flow (annual, 2025-06-30) — Beginning Cash Position: 629619000.00
HGH.AX cash_flow (annual, 2025-06-30) — Capital Expenditure: -4410000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Capital Stock: 1028275000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1028275000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Cash And Cash Equivalents: 632516000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 632516000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 632516000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 632516000.00
HGH.AX cash_flow (annual, 2025-06-30) — Cash Dividends Paid: -37344000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Cash Financial: 356229000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Cash Financial: 356229000.00
HGH.AX cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Financing Activities: -1248847000.00
HGH.AX cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Investing Activities: 304238000.00
HGH.AX cash_flow (annual, 2025-06-30) — Cash Flowsfromusedin Operating Activities Direct: 673199000.00
HGH.AX cash_flow (annual, 2025-06-30) — Changes In Cash: -271410000.00
HGH.AX cash_flow (annual, 2025-06-30) — Classesof Cash Payments: -621456000.00
HGH.AX cash_flow (annual, 2025-06-30) — Classesof Cash Receiptsfrom Operating Activities: 1294655000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Common Stock: 1028275000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Common Stock: 1028275000.00
HGH.AX cash_flow (annual, 2025-06-30) — Common Stock Dividend Paid: -37344000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Common Stock Equity: 1219052000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1219052000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Current Debt: 554243000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Current Debt: 554243000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Current Debt And Capital Lease Obligation: 554243000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 554243000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Current Deferred Liabilities: 1321000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 1321000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Current Deferred Taxes Liabilities: 1321000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Current Deferred Taxes Liabilities: 1321000.00
HGH.AX income_statement (annual, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 21068000.00
HGH.AX income_statement (annual, 2025-06-30) — Depreciation And Amortization In Income Statement: 21068000.00
HGH.AX income_statement (annual, 2025-06-30) — Depreciation Income Statement: 9559000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Derivative Product Liabilities: 20660000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 20660000.00
HGH.AX income_statement (annual, 2025-06-30) — Diluted Average Shares: 936613000.00
HGH.AX income_statement (annual, 2025-06-30) — Diluted EPS: 0.04
HGH.AX cash_flow (annual, 2025-06-30) — Effect Of Exchange Rate Changes: -1980000.00
HGH.AX cash_flow (annual, 2025-06-30) — End Cash Position: 356229000.00
HGH.AX cash_flow (annual, 2025-06-30) — Financing Cash Flow: -1248847000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Foreign Currency Translation Adjustments: -8578000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Foreign Currency Translation Adjustments: -8578000.00
HGH.AX cash_flow (annual, 2025-06-30) — Free Cash Flow: 668789000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -28782000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -28782000.00
HGH.AX income_statement (annual, 2025-06-30) — General And Administrative Expense: 5790000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Goodwill: 204819000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Goodwill: 204819000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Goodwill And Other Intangible Assets: 265222000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 265222000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Gross Accounts Receivable: 7155682000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 7155682000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Gross PPE: 62525000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 62525000.00
HGH.AX cash_flow (annual, 2025-06-30) — Income Tax Paid Supplemental Data: 31420000.00
HGH.AX income_statement (annual, 2025-06-30) — Interest Expense: 398558000.00
HGH.AX income_statement (annual, 2025-06-30) — Interest Income: 705865000.00
HGH.AX cash_flow (annual, 2025-06-30) — Interest Paid Supplemental Data: 410617000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Invested Capital: 2058896000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 2058896000.00
HGH.AX cash_flow (annual, 2025-06-30) — Investing Cash Flow: 304238000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Investments And Advances: 519863000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 519863000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Long Term Debt: 285601000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 285601000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 285601000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 285601000.00
HGH.AX cash_flow (annual, 2025-06-30) — Long Term Debt Payments: -325070000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Long Term Equity Investment: 12641000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 12641000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Machinery Furniture Equipment: 62525000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 62525000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Net Debt: 207328000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Net Debt: 207328000.00
HGH.AX income_statement (annual, 2025-06-30) — Net Income: 38813000.00
HGH.AX income_statement (annual, 2025-06-30) — Net Income Common Stockholders: 38813000.00
HGH.AX income_statement (annual, 2025-06-30) — Net Income Continuous Operations: 38813000.00
HGH.AX income_statement (annual, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 38813000.00
HGH.AX income_statement (annual, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 38813000.00
HGH.AX income_statement (annual, 2025-06-30) — Net Income Including Noncontrolling Interests: 38813000.00
HGH.AX income_statement (annual, 2025-06-30) — Net Interest Income: 307307000.00
HGH.AX cash_flow (annual, 2025-06-30) — Net Investment Purchase And Sale: 307244000.00
HGH.AX cash_flow (annual, 2025-06-30) — Net Issuance Payments Of Debt: -325070000.00
HGH.AX cash_flow (annual, 2025-06-30) — Net Long Term Debt Issuance: -325070000.00
HGH.AX cash_flow (annual, 2025-06-30) — Net Other Financing Charges: -886433000.00
HGH.AX cash_flow (annual, 2025-06-30) — Net Other Investing Changes: 1404000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Net PPE: 49497000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Net PPE: 49497000.00
HGH.AX cash_flow (annual, 2025-06-30) — Net PPE Purchase And Sale: -4410000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Net Tangible Assets: 953830000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 953830000.00
HGH.AX income_statement (annual, 2025-06-30) — Normalized Income: 38813000.00
HGH.AX income_statement (annual, 2025-06-30) — Occupancy And Equipment: 3414000.00
HGH.AX income_statement (annual, 2025-06-30) — Operating Revenue: 319129000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Ordinary Shares Number: 940100000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 940100000.00
HGH.AX cash_flow (annual, 2025-06-30) — Other Cash Receiptsfrom Operating Activities: 828553000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Other Current Borrowings: 554243000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 554243000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Other Equity Adjustments: -20204000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -20204000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Other Intangible Assets: 60403000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 60403000.00
HGH.AX income_statement (annual, 2025-06-30) — Other Non Interest Expense: 157093000.00
HGH.AX income_statement (annual, 2025-06-30) — Other Non Operating Income Expenses: 6556000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Other Payable: 20167000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Other Payable: 20167000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Other Receivables: 12018000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Other Receivables: 12018000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Other Short Term Investments: 505048000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 505048000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Payables: 36620000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Payables: 36620000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Payables And Accrued Expenses: 36620000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 36620000.00
HGH.AX income_statement (annual, 2025-06-30) — Pretax Income: 57205000.00
HGH.AX income_statement (annual, 2025-06-30) — Professional Expense And Contract Services Expense: 9477000.00
HGH.AX cash_flow (annual, 2025-06-30) — Purchase Of Investment: -1725457000.00
HGH.AX cash_flow (annual, 2025-06-30) — Purchase Of PPE: -4410000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Receivables: 7094417000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Receivables: 7094417000.00
HGH.AX income_statement (annual, 2025-06-30) — Reconciled Depreciation: 21068000.00
HGH.AX cash_flow (annual, 2025-06-30) — Repayment Of Debt: -325070000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Retained Earnings: 219559000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 219559000.00
HGH.AX income_statement (annual, 2025-06-30) — Salaries And Wages: 5790000.00
HGH.AX cash_flow (annual, 2025-06-30) — Sale Of Investment: 2032701000.00
HGH.AX income_statement (annual, 2025-06-30) — Selling General And Administration: 5790000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Share Issued: 940100000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Share Issued: 940100000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Stockholders Equity: 1219052000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1219052000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Tangible Book Value: 953830000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 953830000.00
HGH.AX income_statement (annual, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
HGH.AX income_statement (annual, 2025-06-30) — Tax Provision: 18392000.00
HGH.AX income_statement (annual, 2025-06-30) — Tax Rate For Calcs: 0.32
HGH.AX balance_sheet (annual, 2025-06-30) — Total Assets: 8647450000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Total Assets: 8647450000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Total Capitalization: 1504653000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1504653000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Total Debt: 839844000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Total Debt: 839844000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Total Equity Gross Minority Interest: 1219052000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1219052000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Total Liabilities Net Minority Interest: 7428398000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 7428398000.00
HGH.AX balance_sheet (annual, 2025-06-30) — Trading Securities: 2174000.00
HGH.AX balance_sheet (quarterly, 2025-06-30) — Trading Securities: 2174000.00
HGINFRA.NS income_statement (annual, 2022-03-31) — +Operating Expense: 1457890000.00
HGINFRA.NS income_statement (annual, 2022-03-31) — +Total Revenue: 36420240000.00
HGINFRA.NS balance_sheet (annual, 2022-03-31) — Accounts Payable: 4320240000.00
HGINFRA.NS balance_sheet (annual, 2022-03-31) — Accounts Receivable: 6353980000.00
HGINFRA.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -3605790000.00
HGINFRA.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 2694470000.00
HGINFRA.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -50160000.00
HGINFRA.NS income_statement (annual, 2022-03-31) — Amortization: 8230000.00
HGINFRA.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 8230000.00
HGINFRA.NS balance_sheet (annual, 2022-03-31) — Assets Held For Sale Current: 9630000.00
HGINFRA.NS balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 9106460000.00
HGINFRA.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 65171111.00
HGINFRA.NS income_statement (annual, 2022-03-31) — Basic EPS: 58.31
HGINFRA.NS cash_flow (annual, 2022-03-31) — Beginning Cash Position: 1441430000.00
HGINFRA.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 91780000.00
HGINFRA.NS cash_flow (annual, 2022-03-31) — Capital Expenditure: -676060000.00